Work

639TiP KEYNOTE-365 cohort I: Phase Ib/II study of platinum containing chemotherapy in combination with pembrolizumab and chemotherapy alone for treatment-emergent neuroendocrine prostate carcinoma (t-NE)

Year: 2021

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2021.08.1152

Authors: N.D. Shore, G. Kramer, A.M. Joshua, X.T. Li, C.H. Poehlein, C. Schloss, J.S. de Bono, E. Yu

Institutions: Carolina Urologic Research Center, Medical University of Vienna, St Vincent's Hospital Sydney, Merck & Co., Inc., Rahway, NJ, USA (United States), Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, University of Washington

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Merck Sharp and Dohme

OpenAlex ID: W3202169727

FWCI:

Cites:

Cited by:

Related to: 10